MC10 grabs $19.8M more to advance stretchable sensors for med tech

The Bay State's MC10--a maker of stretchable sensors useful for medical devices and other applications--reeled in $19.8 million in new funding, according to a regulatory filing.

The Boston Business Journal reported on Cambridge-based MC10's latest equity financing, which comes on top of an $18 million funding round in April. MC10's filing doesn't disclose the investors behind the round. But as the BBJ noted, Braemar Energy Ventures and North Bridge Venture Partners are among the company's previous investors. Medtronic ($MDT) is also an investor and has partnered with MC10 to use its BioStamp stretchable sensor technology in a balloon catheter, a bid to develop a device that can open up vessels and simultaneously collect data on heart function and potential vascular problems.

In July, MC10 heralded a deal with Reebok ($RBK) that produced a device worn on the head to detect head trauma severity in contact sports such as football. While not designed to function as a diagnostic, the product is designed to help reduce the risk of serious injury by determining an athlete's condition on the field.

- here's the SEC filing
- check out the BBJ's take

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

A COVID-19 antibody diagnostic developed through a joint venture between Mount Sinai Health System and RenalytixAI has been authorized by the FDA.

Researchers at Northwestern University have trained an AI algorithm to automatically detect the signs of COVID-19 on a basic X-ray of the lungs.

Hand-held ultrasound developer Butterfly Network is going public through a $1.5 billion acquisition deal backed by Glenview Capital.